These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1181 related articles for article (PubMed ID: 30976087)

  • 1. Microbes, metabolites, and the gut-lung axis.
    Dang AT; Marsland BJ
    Mucosal Immunol; 2019 Jul; 12(4):843-850. PubMed ID: 30976087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of gut microbes and host's immune response in gut-lung homeostasis.
    Rastogi S; Mohanty S; Sharma S; Tripathi P
    Front Immunol; 2022; 13():954339. PubMed ID: 36275735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
    Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
    Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
    Gonçalves P; Araújo JR; Di Santo JP
    Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Local Defender and Functional Mediator: Gut Microbiome.
    Yang H; Duan Z
    Digestion; 2018; 97(2):137-145. PubMed ID: 29310114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From gut microbiota dysfunction to obesity: could short-chain fatty acids stop this dangerous course?
    Barrea L; Muscogiuri G; Annunziata G; Laudisio D; Pugliese G; Salzano C; Colao A; Savastano S
    Hormones (Athens); 2019 Sep; 18(3):245-250. PubMed ID: 30840230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological Role of Gut Microbiota for Maintaining Human Health.
    Andoh A
    Digestion; 2016; 93(3):176-81. PubMed ID: 26859303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism at the centre of the host-microbe relationship.
    Maslowski KM
    Clin Exp Immunol; 2019 Aug; 197(2):193-204. PubMed ID: 31107965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life.
    Takiishi T; Fenero CIM; Câmara NOS
    Tissue Barriers; 2017 Oct; 5(4):e1373208. PubMed ID: 28956703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis.
    Wang J; Zhu N; Su X; Gao Y; Yang R
    Cells; 2023 Mar; 12(5):. PubMed ID: 36899929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Molecular Mechanisms Underlying the Protective Effects of Microbial SCFAs on Intestinal Tolerance and Food Allergy.
    Luu M; Monning H; Visekruna A
    Front Immunol; 2020; 11():1225. PubMed ID: 32612610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
    Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
    Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in host-microbe metabolic axis].
    Pi Y; Gao K; Zhu W
    Wei Sheng Wu Xue Bao; 2017 Feb; 57(2):161-9. PubMed ID: 29750478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging intestinal immunity and gut microbiota by metabolites.
    Wang G; Huang S; Wang Y; Cai S; Yu H; Liu H; Zeng X; Zhang G; Qiao S
    Cell Mol Life Sci; 2019 Oct; 76(20):3917-3937. PubMed ID: 31250035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastro-intestinal tract: The leading role of mucosal immunity.
    Steinert A; Radulovic K; Niess J
    Swiss Med Wkly; 2016; 146():w14293. PubMed ID: 27045424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puerarin improves the bone micro-environment to inhibit OVX-induced osteoporosis via modulating SCFAs released by the gut microbiota and repairing intestinal mucosal integrity.
    Li B; Liu M; Wang Y; Gong S; Yao W; Li W; Gao H; Wei M
    Biomed Pharmacother; 2020 Dec; 132():110923. PubMed ID: 33125971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
    Peng K; Xia S; Xiao S; Yu Q
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.